These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 19021058)

  • 1. Prospective monocentric study of non-tunnelled central venous catheter-related complications in hematological patients.
    Nosari AM; Nador G; De Gasperi A; Ortisi G; Volonterio A; Cantoni S; Nichelatti M; Marbello L; Mazza E; Mancini V; Ravelli E; Ricci F; Ciapanna D; Garrone F; Gesu G; Morra E
    Leuk Lymphoma; 2008 Nov; 49(11):2148-55. PubMed ID: 19021058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of and risk factors for venous thrombosis in children with percutaneous non-tunnelled central venous catheters.
    Östlund Å; Fläring U; Norberg Å; Dahlberg A; Berner J; Kaiser S; Vermin L; Svenningsson A; Frisk T; Larsson P; Andersson A
    Br J Anaesth; 2019 Sep; 123(3):316-324. PubMed ID: 31176448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central venous catheter-related complications in children with oncological/hematological diseases: an observational study of 418 devices.
    Fratino G; Molinari AC; Parodi S; Longo S; Saracco P; Castagnola E; Haupt R
    Ann Oncol; 2005 Apr; 16(4):648-54. PubMed ID: 15677621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of catheter-related infections in neutropenic patients: a prospective controlled randomized trial using a chlorhexidine and silver sulfadiazine-impregnated central venous catheter.
    Jaeger K; Zenz S; Jüttner B; Ruschulte H; Kuse E; Heine J; Piepenbrock S; Ganser A; Karthaus M
    Ann Hematol; 2005 Apr; 84(4):258-62. PubMed ID: 15549302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cohort Study: Central Venous Catheter-Related Complications in Children with Hematologic Diseases at a Single Center.
    Pektaş A; Kara A; Gurgey A
    Turk J Haematol; 2015 Jun; 32(2):144-51. PubMed ID: 26316482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Complications associated with central venous catheters in patient with hematologic neoplasms or hematopoietic transplants].
    Gutiérrez AM; Solano C; Gimeno C; García-Conde J
    Sangre (Barc); 1999 Jun; 44(3):171-5. PubMed ID: 10481576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low infection rate and long durability of nontunneled silastic catheters. A safe and cost-effective alternative for long-term venous access.
    Raad I; Davis S; Becker M; Hohn D; Houston D; Umphrey J; Bodey GP
    Arch Intern Med; 1993 Aug; 153(15):1791-6. PubMed ID: 8392831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of the Insertion Site on Central Venous Catheter-Related Complications in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation.
    Heidenreich D; Hansen E; Kreil S; Nolte F; Jawhar M; Hecht de Gutierrez A; Hofmann WK; Klein SA
    Biol Blood Marrow Transplant; 2020 Jun; 26(6):1189-1194. PubMed ID: 32084541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central venous catheter-related complications in patients with hematological malignancies: a retrospective analysis of risk factors and prophylactic measures.
    Cortelezzia A; Fracchiolla NS; Maisonneuve P; Moia M; Luchesini C; Ranzi ML; Monni P; Pasquini MC; Lambertenghi-Deliliers G
    Leuk Lymphoma; 2003 Sep; 44(9):1495-501. PubMed ID: 14565650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central venous catheter infections in patients with acute leukemia.
    Karthaus M; Doellmann T; Klimasch T; Krauter J; Heil G; Ganser A
    Chemotherapy; 2002 Jul; 48(3):154-7. PubMed ID: 12138333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comprehensive approach to the prevention of central venous catheter complications: results of 10-year prospective surveillance in pediatric hematology-oncology patients.
    Cesaro S; Cavaliere M; Pegoraro A; Gamba P; Zadra N; Tridello G
    Ann Hematol; 2016 Apr; 95(5):817-25. PubMed ID: 26961934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of a long-term, prospective study on complications of central venous catheter in pediatric patients with hematologic-oncologic diseases.
    Garonzi C; Zeni F; Tridello G; Giacomazzi A; Castagna A; Esposto MP; Caddeo G; Pezzella V; Zaccaron A; Bonetti E; Vitale V; Chinello M; Balter R; Guardini B; Pedrazzoli E; Cesaro S
    Pediatr Blood Cancer; 2024 Jul; 71(7):e30990. PubMed ID: 38605511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective survey on incidence and outcome of Broviac/Hickman catheter-related complications in pediatric patients affected by hematological and oncological diseases.
    Cesaro S; Corrò R; Pelosin A; Gamba P; Zadra N; Fusaro F; Pillon M; Cusinato R; Zampieri C; Magagna L; Cavaliere M; Tridello G; Zanon G; Zanesco L
    Ann Hematol; 2004 Mar; 83(3):183-8. PubMed ID: 15064868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nontunneled central venous catheters in patients with AIDS are associated with a low infection rate.
    Skiest DJ; Grant P; Keiser P
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Mar; 17(3):220-6. PubMed ID: 9495221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study on risk factor of central venous catheter infection in ICU: 1 160 patients report].
    Zhang M; Xu Y; Jiang Z; Qian J; Zhang Z; Sun N; Xie J; Li T
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 Dec; 29(12):1082-1086. PubMed ID: 29216940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective study of the use of central venous catheters in patients newly diagnosed with acute myeloid leukemia treated with induction chemotherapy.
    McKeown C; Ricciuti A; Agha M; Raptis A; Hou JZ; Farah R; Redner RL; Im A; Dorritie KA; Sehgal A; Rossetti J; Lontos K; Bovbjerg DH; Normolle D; Boyiadzis M
    Support Care Cancer; 2022 Feb; 30(2):1673-1679. PubMed ID: 34562168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Infectious and non-infectious complications of tunneled central catheters in hematologic patients].
    Albo López C; López Rodríguez D; Constenla Camba MI; Jimenéz Blanco A; Araujo LF; García-Medina J
    Sangre (Barc); 1999 Jun; 44(3):176-81. PubMed ID: 10481577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central venous catheter-related Stenotrophomonas maltophilia bacteraemia and associated relapsing bacteraemia in haematology and oncology patients.
    Lai CH; Wong WW; Chin C; Huang CK; Lin HH; Chen WF; Yu KW; Liu CY
    Clin Microbiol Infect; 2006 Oct; 12(10):986-91. PubMed ID: 16961635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Five-Lumen Antibiotic-Impregnated Femoral Central Venous Catheters in Severely Burned Patients: An Investigation of Device Utility and Catheter-Related Bloodstream Infection Rates.
    Friedman BC; Mian MA; Mullins RF; Hassan Z; Shaver JR; Johnston KK
    J Burn Care Res; 2015; 36(4):493-9. PubMed ID: 25407386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective, randomized trial of two different modalities of flushing central venous catheters in pediatric patients with cancer.
    Cesaro S; Tridello G; Cavaliere M; Magagna L; Gavin P; Cusinato R; Zadra N; Franco Zanon G; Zanesco L; Carli M
    J Clin Oncol; 2009 Apr; 27(12):2059-65. PubMed ID: 19273702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.